Small Cell Ovarian Cancer in Adolescents: Report of Two Cases and Review of the Literature by M. Rovithi, A. G. Pallis, A. Kalykaki, E. Lagoudaki, L. Giannikaki, E. N. Stathopoulos, K. Relakis, V. Georgoulias

“…Although combination chemotherapy remains the cornerstone of treatment due to the rarity of these tumors, no regimen can be recommended as standard of care although in the majority of cases platinum-based regimens are used. …”
Get full text

Peripheral Cytotoxic T Cell Lymphoma of the Appendix Presenting as Acute Appendicitis by Negin Rahmani, Yahya Daneshbod, Hadi Mirfazaelian, Elnaz Vahidi, Sadegh Shirian

“…In addition, since there is no standard chemotherapy regimen for cytotoxic PTCL, this and other case reports hopefully help in providing the clinical evidence needed for establishing appropriate treatment guidelines.…”
Get full text

Erythropoietin: from erythropoiesis to cardioprotection by Liermis Michael Dita Salabert, Ivis Mendoza Hernández, Rafael Alejandro Gómez Baute, Elena García López, Lázaro E. de la Cruz Avilés, Aramis Núñez Quintana

“…Within this group stand anthracyclines, identified as the type of chemotherapy most likely to cause heart damage, short or long term. …”
Get full text

New bispecific antibodies in diffuse large B-cell lymphoma by Adrian G. Minson, Michael J. Dickinson

“…These agents can be safely combined with other immunotherapies and chemotherapy, and single-arm and randomised trial outcomes promise an expanding role for this class of drugs in earlier treatment lines. …”
Get full text

Effects of Cisplatin in Neuroblastoma Rat Cells: Damage to Cellular Organelles by Giada Santin, Luigi Scietti, Paola Veneroni, Sergio Barni, Graziella Bernocchi, Maria Grazia Bottone

“…Cisplatin (cisPt) is a chemotherapy agent used as a treatment for several types of cancer. …”
Get full text

Primary Breast Angiosarcoma: Avoiding a Common Trap by Christine Desbiens, Jean-Charles Hogue, Yves Lévesque

“…There is a lack of data proving efficacy of adjuvant chemotherapy and radiation therapy.…”
Get full text

Lambert-Eaton Myasthenic Syndrome Secondary to Nivolumab and Ipilimumab in a Patient with Small-Cell Lung Cancer by Kavita Agrawal, Nirav Agrawal

“…He had progressive disease even after four cycles of cisplatin and etoposide chemotherapy and 21 cycles of radiation. He was therefore started on immunotherapy with nivolumab every 2 weeks and ipilimumab every 6 weeks. …”
Get full text

Oral Floor and Gingival Metastasis of Cholangiocarcinoma: A Case Report and Review of the Literature by Yukihiro Nakanishi, Bo Xu, Charles LeVea

“…After undergoing one cycle of gemcitabine chemotherapy, the patient noticed an extremely rapidly growing mass involving her right lower gingiva and the entire right floor of her mouth. …”
Get full text

Ferroptosis and pyroptosis are connected through autophagy: a new perspective of overcoming drug resistance by Peng Zhao, Shuangshuang Yin, Yuling Qiu, Changgang Sun, Haiyang Yu

“…The effectiveness of combining chemotherapy drugs with autophagy inducers/inhibitors has been widely confirmed, but the mechanisms are still unclear. …”
Get full text

An Optimal Algorithm for Determining Risk Factors for Complex Diseases: Depressive Disorder, Osteoporosis, and Fracture in Young Patients with Breast Cancer Receiving Curative Surg... by Chieh-Yu Liu, Chun-Hung Chang

“…The results revealed that depressive disorder, osteoporosis, and fracture were clustered with liver cirrhosis, chronic obstructive pulmonary disease (COPD), distant metastasis, and primary metastatic and adjuvant therapies, namely, chemotherapy, radiotherapy, tamoxifen, aromatase inhibitors, and trastuzumab. …”
Get full text

Trafficked Proteins—Druggable in Plasmodium falciparum? by Jasmin Lindner, Kamila Anna Meissner, Isolmar Schettert, Carsten Wrenger

“…An effective vaccine is not available, and the treatment of the disease is solely dependent on chemotherapy. However, drug resistance is spreading, and the identification of new drug targets as well as the development of new antimalarials is urgently required. …”
Get full text

A Rare Case of Erdheim-Chester Disease (Non-Langerhans Cell Histiocytosis) with Concurrent Langerhans Cell Histiocytosis: A Diagnostic and Therapeutic Challenge by Hamza Hashmi, Drew Murray, John Greenwell, Marwan Shaikh, Soumit Basu, Maxwell Krem

“…For patients who are either intolerant or nonresponsive to interferon alpha, systemic chemotherapy with or without corticosteroids can be used. …”
Get full text

Advancements in Nanorobots: Innovating Bladder Cancer Treatments, Diagnosis and Patient Outcomes by Zehra Hussain, Alyssa Di Fonzo, Hermela Merhawi, Mary Gallant, Robert Girlan, Muhammad Hasibul Hasan

“… Nanorobots are an emerging technology that can deliver cancer treatment with increased precision, potentially decreasing unintended side effects commonly seen with surgery, chemotherapy, and radiation therapy. Recent advancements in in vivo trials have demonstrated significant tumor reduction in mice with bladder cancer, showing the potential of nanorobots to not only treat but also improve diagnostic capabilities in cancer therapy. …”
Get full text

C-Reactive Protein and Breast Cancer: New Insights from Old Molecule by Shilpa Balaji Asegaonkar, Balaji Narayanrao Asegaonkar, Unmesh Vidyadhar Takalkar, Suresh Advani, Anand Pandurang Thorat

“…Also, it is a risk predictor for subsequent cardiotoxicity in patients receiving chemotherapy. The present review is aimed at elucidating the role of C-reactive protein, as an inflammatory risk marker and prognostic predictor of breast cancer. …”
Get full text

Recognition and Treatment of BCG Failure in Bladder Cancer by Andrew J. Lightfoot, Henry M. Rosevear, Michael A. O'Donnell

“…In this setting, treatment options are limited and include repeat BCG treatment, an alternate immunotherapy regimen, chemotherapy, or device-assisted therapy. To date, however, further research is necessary for all secondary treatment options in order to determine which might be the most efficacious. …”
Get full text

Angiosarcoma of Small Bowel Presenting with Obstruction: Novel Observations on a Rare Diagnostic Entity with Unique Clinical Presentation by Richard Siderits, Frederick Poblete, Biren Saraiya, Cheryl Rimmer, Anup Hazra, Le Aye

“…We present a case of angiosarcoma in small bowel, presenting with partial small bowel obstruction in a 79-year-old man with no history of radiation, chemotherapy, toxin exposure, or previous operative intervention. …”
Get full text

Ewing Sarcoma of the External Ear Canal by Adem Binnetoglu, Tekin Baglam, Gulnur Tokuc, Kiymet Kecelioglu Binnetoglu, Fatma Gerin, Murat Sari

“…Surgery was performed and a VAC/IE (vincristine, adriamycin, cyclophosphamide alternating with ifosfamide, and etoposide) regimen was used for adjuvant chemotherapy for 12 months. Conclusion. The clinician should consider extraskeletal ES when diagnosing tumors localized in the head and neck region because it may be manifested by a nonspecific clinical picture mimicking common otorhinolaryngologic disorders.…”
Get full text

Diagnosis and Treatment of Esophageal Candidiasis: Current Updates by Abdimajid Ahmed Mohamed, Xin-liang Lu, Faycal Awaleh Mounmin

“…Immunocompromised patients are most at risk, including patients with HIV/AIDS, leukemia, diabetics, and those who are receiving corticosteroids, radiation, and chemotherapy. Another group includes those who used antibiotics frequently and those who have esophageal motility disorder (cardiac achalasia and scleroderma). …”
Get full text

Synovial Sarcoma of the Hand by Hovsep Ohan, Greg Minassian, Asaad H. Samra, Matthew J. Zdilla

“…Resection of the mass was followed by radiation and chemotherapy. The patient had a long-term follow-up of 3.5 years with no evidence of any local recurrence of the tumor. …”
Get full text

Targeting Apoptosis Pathways in Cancer with Alantolactone and Isoalantolactone by Azhar Rasul, Muhammad Khan, Muhammad Ali, Jiang Li, Xiaomeng Li

“…This review suggests that alantolactone and isoalantolactone are potential promising anticancer candidates, but additional studies and clinical trials are required to determine their specific intracellular sites of actions and derivative targets in order to fully understand the mechanisms of therapeutic effects to further validate in cancer chemotherapy.…”
Get full text